EGFR and cancer: Notably, in a recent project for prioritization of cancer antigens, 4 of the 75 selected antigens were gangliosides (GD2, GD3, fucosyl-GM1, and N-acetyl GM3), and additional targets, like the EGFR and the VEGFR, are known to interact with gangliosides (141).